Metastatic Breast Cancer News

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

by steve | Sep 8, 2017 | Metastatic Breast Cancer News

Author: Barbara Jacoby / Source: Let Life Happen From: PR Newswire — Breakthrough Therapy designation received for the treatment of patients with HER2-positive, locally advanced or metastatic breast...

Finding the Right Place for Dual HER2 Blockade in Breast Cancer and Beyond

by steve | Sep 5, 2017 | Metastatic Breast Cancer News

Source: OncLive Although drugs that target HER2 have transformed the prognosis for many patients with breast cancer, the development of resistant disease remains a significant clinical challenge....

Learn More:

Did you know?

That Bob and Linda Carey do not use foundation dollars to create these iconic images? In most cases, they take personal road trips to escape the difficult days a cancer diagnosis can cause.

In some amazing cases, a 'Company that Cares' will sponsor an image. This creates a win-win partnership. Our corporate sponsors get to show their support for breast cancer patients while funding our foundation.
If you are interested in speaking to us about a partnership, please contact Linda Carey at the Carey Foundation directly: 201-785-7974 or send us a quick note.

Metastatic Breast Cancer News

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

Finding the Right Place for Dual HER2 Blockade in Breast Cancer and Beyond

Categories

Learn More:

Did you know?

Pin It on Pinterest